20.760 articles found

Characterisation of metabotropic glutamate receptor 4 as a therapeutic target in Parkinson's disease

Mann EC.

· 2019-01-01

Ursodeoxycholic acid as a putative treatment for Parkinson's disease : in vitro study of the cytoprotective effect

Karami M.

· 2019-01-01

The potential application of rapeseed pomace extracts in the prevention and treatment of neurodegenerative diseases

Pohl F.

· 2019-01-01

Exploration and manipulation of cellular pathways for treatment of neurodegeneration

Fears K.

· 2019-01-01

Translational requirements for manufactured dopaminergic neurons for the treatment of Parkinson's disease

Kusena J.

· 2019-01-01

DOI: 10.26174/thesis.lboro.11662458.v1

Synthesis and biological evaluation of metal chelators of the hydroxypyridinone family as potential treatment of Parkinson's disease and cancer

Kyriakou S.

· 2019-01-01

Nicotine Gum as a Therapeutic Approach for Low Blood Pressure in Parkinson's Disease: A Randomized Pilot Study.

DiFrancisco-Donoghue J, Jung MK, Leder A.

Nicotine Tob Res · 2019-01-01

DOI: 10.1093/ntr/ntx263PMID: 29228369

Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential.

Fan D, Liu L, Wu Z, Cao M.

Curr Neuropharmacol · 2019-01-01

DOI: 10.2174/1570159x16666180419141613PMID: 29676231

Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia.

Hauser RA, Pahwa R, Wargin WA, Souza-Prien CJ, McClure N, Johnson R, Nguyen JT, Patni R, Went GT.

Clin Pharmacokinet · 2019-01-01

DOI: 10.1007/s40262-018-0663-4PMID: 29777529

Mesenchymal stem cell transplantation and aerobic exercise for Parkinson's disease: therapeutic assets beyond the motor domain.

Berrío Sánchez J, Cucarian Hurtado J, Barcos Nunes R, de Oliveira AA.

Rev Neurosci · 2019-01-01

DOI: 10.1515/revneuro-2018-0011PMID: 29959887

Pleiotropic Effects of Statins: Untapped Potential for Statin Pharmacotherapy.

Mohammad S, Nguyen H, Nguyen M, Abdel-Rasoul M, Nguyen V, Nguyen CD, Nguyen KT, Li L, Kitzmiller JP.

Curr Vasc Pharmacol · 2019-01-01

DOI: 10.2174/1570161116666180723120608PMID: 30033872

Traumatic Brain Injury Altered Normal Brain Signaling Pathways: Implications for Novel Therapeutics Approaches.

Rana A, Singh S, Sharma R, Kumar A.

Curr Neuropharmacol · 2019-01-01

DOI: 10.2174/1570159x16666180911121847PMID: 30207236